A high spatial resolution 1H magnetic resonance spectroscopic imaging technique for breast cancer with a short echo time

Magnetic Resonance Imaging

Volumn 26, Issue 3, 2008, Pages 360-366

  Hu, Jiani ^a   Yu, Yingjian ^a   Kou, Zhifeng ^a   Huang, Wei ^c   Jiang, Quan ^d   Xuan, Yang ^a   Li, Tao ^a   Sehgal, Vivek ^a   Blake, Cassann ^b   Haacke, E Mark ^a   Soulen, Renate L ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d HENRY FORD HOSPITAL   (United States)

Author keywords

Breast cancer; Echo filter; High spatial resolution; Magnetic resonance spectroscopy; Short TE

Indexed keywords

CHOLINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROADENOMA; HUMAN; IN VIVO STUDY; MAGNETIC FIELD; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROSCOPY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 40149086087     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2007.07.004     Document Type: Article

References (44)

1. Kneeshaw P., Turnbull L., and Drew P. Current applications and future direction of MR mammography. Br J Cancer 88 (2003) 4-10
2. Rieber A., Schramm K., Helms G., von Puckler S., Nuessle K., Kreienberg R., et al. Breast-conserving surgery and autogenous tissue reconstruction in patients with breast cancer: efficacy of MRI of the breast in the detection of recurrent disease. Eur Radiol 13 (2003) 780-787
3. Partridge S., Gibbs J., Lu Y., Esserman L., Sudilovsky D., and Hylton N. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179 (2002) 1193-1199
4. Liberman L., Morris E., Dershaw D., Abramson A., and Tan L. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 180 (2002) 901-910
5. Kaiser W., and Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 170 (1989) 681-686
6. Gilles R., Guinebretiere J., Lucidarme O., Cluzel P., Janaud G., Finet J., et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 191 (1994) 625-631
7. Boetes C., Barentsz J., Mus R., van der Sluis R., van Erning L., Hendriks J., et al. MR characterization of suspicious breast lesions with a Gd-enhanced TurboFlash subtraction technique. Radiology 193 (1994) 777-781
8. Chenevert T., Helvie M., Aisen A., Francis I., Adler D., Roubidoux M., et al. Dynamic three-dimensional imaging with partial k-space sampling: initial application for Gd-enhanced rate of characterization of breast lesions. Radiology 196 (1995) 135-142
9. Kelcz F., Santyr G., Cron G., and Mongin S. Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic, Gd-enhanced MRI. J Magn Reson Imaging 6 (1996) 743-752
10. Muller-Schimpfle M., Ohmenhauser K., Sand J., Stoll P., and Claussen C. Dynamic 3D-MR mammography: is there a benefit of sophisticated evaluation of enhancement curves for clinical routine?. J Magn Reson Imaging 7 (1997) 236-240
11. Wiberg M., Bone B., Bronge L., and Aspelin P. Comparison of the contrast enhancement pattern in two different T1-weighted 3D sequences in MR imaging of the breast. Acta Radiol 39 (1998) 680-685
12. Nunes L., Schnall M., Orel S., Hochman M., Lauglotz C., Reynolds C., et al. Correlation of lesion appearance and histological findings for the nodes of a breast MR imaging interpretation model. Radiographics 19 (1999) 79-92
13. Yen Y., Han K., Daniel B., Heiss S., Birdwell R., Herfkens R., et al. Dynamic breast MRI with spiral trajectories: 3D versus 2D. J Magn Reson Imaging 11 (2000) 351-359
14. Kuhl C., Morakkabati N., Leutner C., Schmiedel A., Wardelmann E., and Schild H. MR imaging-guided large-core(14 gauge) needle biopsy of small lesions visible at breast MR imaging alone. Radiology 220 (2001) 31-39
15. Lee G., Orel S., Woo I., Cruz-Jove E., Putt M., Solin L., et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 226 (2003) 773-778
16. Liberman L., Morris E., Kim C., Kaplan J., Abramson A., Menell J., et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 180 (2003) 333-341
17. Nelson S. Magnetic resonance spectroscopic imaging: evaluating response to therapy for gliomas. IEEE Eng Med Biol Mag (2004) 30-39
18. Yeung D.K., Cheung H.S., and Tse G.M. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy - initial results. [comment]. . Radiology 220 1 (2001) 40-46
19. Thomas M., Binesh N., Yue K., and DeBruhl N. Volume-localized two-dimensional correlated magnetic resonance spectroscopy of human breast cancer. J Magn Reson Imaging 14 (2001) 181-186
20. Cecil K., Schnall M., ES S., and Lenkinski R. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 68 (2001) 45-54
21. Gribbestad I., Sitter B., Lundgren S., Krane J., and Axelson D. Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res 19 (1999) 1737-1746
22. Gribbestad I.S., Singstad T.E., Nilsen G., Fjosne H.E., Engan T., Haugen O.A., et al. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging 8 6 (1998) 1191-1197
23. Roebuck J.R., Cecil K.M., Schnall M.D., and Lenkinski R.E. Human breast lesions: characterization with proton MR spectroscopy. Radiology 209 1 (1998) 269-275
24. Kvistad K.A., Bakken I.J., Gribbestad I.S., Ehrnholm B., Lundgren S., Fjosne H.E., et al. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging 10 2 (1999) 159-164
25. Kim J., Park S., Lee H., et al. In vivo 1H-MRS evaluation of malignant and benign breast diseases. Breast 12 (2003) 179-182
26. Meisamy S., Bolan P., Baker E.P., M G., Le C., Kelcz F., et al. Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0T. Radiology 236 (2005) 465-475
27. Bolan P., Meisamy S., Baker E., Lin J., Emory T., Nelson M., et al. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 50 (2004) 1134-1143
28. Huang W., Fisher P., Dulaimy K., Tudorica L., Hea B., and Button T. Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 232 (2004) 585-591
29. Baik H., Su M., Yu H., Mehta R., and Nalcioglu O. Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5T. MAGMA 19 (2006) 96-104
30. Gluch L. Magnetic resonance in surgical oncology: II - Literature review. ANZ J Surg 75 (2005) 464-470
31. Aboagye E., and Bhujwalla Z. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 59 (1999) 80-84
32. Katz-Brull R., Lavin P., and Lenkinski R.E. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 94 (2002) 1197-1203
33. Jagannathan N.R., Kumar M., Seenu V., Coshic O., Dwivedi S.N., Julka P.K., et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 84 8 (2001) 1016-1022
34. Jacobs M., Barker P., Bottomley P., Bhujwalla Z., and Bluemke D. Proton MR spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 2004 19 (2004) 68-75
35. Jacobs M., Barker P., Argani P., Ouwerkerk R., Bhujwalla Z., and Bluemke D. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging 21 (2005) 23-28
36. Hu J., Vartanian S., Xuan Y., Latif Z., and Soulen R. An improved 1H magnetic resonance spectroscopic imaging technique for the human breast: preliminary results. Magn Reson Imaging 23 (2005) 571-576
37. Chen W., and Hu J. Mapping brain metabolites using the double echo-filter metabolic imaging (DEFMI) technique. J Magn Reson 140 (1999) 363-370
38. Hu J., Jiang Q., Xia Y., and Zuo C. High spatial resolution in vivo 1H magnetic resonance spectroscopic imaging of human muscles with band-selective techniques. Magn Reson Imaging 19 (2001) 1091-1096
39. Kuhn B., Dreher W., Norris D., and Leibfritz D. Fast proton spectroscopic imaging employing k-space weighting achieved by variable repetition times. Magn Reson Med 35 (1996) 457-464
40. Maudsley A., Matson G., Hugg J., and Weiner M. Reduced phase encoding in spectroscopic imaging. Magn Reson Med 31 (1994) 645-651
41. Scheenen T., Klomp D., Roll S., Futterer J., Barentsz J., and Heerschap A. Fast acquisition-weighted three-dimension proton MR spectroscopic imaging of the human prostate. Magn Reson Med 52 (2004) 80-88
42. Mountford C., Somorjai R., Malycha P., Gluch L., Lean C., Russell P., et al. Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analyzed using a statistical classification strategy. Br J Surg 88 (2000) 1234-1240
43. Haacke E.M., Brown R.W., Thompson M.R., and Venkatesan R. Magnetic resonance imaging: Physical principles and sequence design (1999), John Wiley & Sons, New York 741-781 (Chapter 725)
44. Griffin J., Lehtimaki K., Valonen P., Grohn O., Kettunen M., Yla-Herttuala S., et al. Assignment of 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing gabciclovir-thymidine kinase gene therapy-induced programmed cell death. Cancer Res 63 (2003) 3195-3201